Concalls & earnings callsFortis Healthcare Limited
Every summarised call, newest first. Latest is Q1 FY27, held 4 Sept 2026.
Q1 FY27 snapshot
Open full brief →Delhi High Court ordered a court-supervised forensic audit into erstwhile promoter share dissipation, IHH's acquisition of control and use of funds for RHT assets, which Fortis and IHH say leaves operations, capex, bed expansion and M&A unrestricted and is expected to have no material adverse outcome.
- Strategic and operational plans including investment, capex, bed expansion and M&A initiatives continue with no restriction on corporate actions within the remit of law.
- IHH remains fully backing Fortis, happy to infuse capital for growth needs and to pursue merging Gleneagles and Fortis at the appropriate time.
- Forensic audit timeline set by court is 4 weeks for auditor questionnaire, 2 weeks to respond, and 6 months for report, with further court steps thereafter.
- No provisioning required as no liability has been fixed; only ongoing legal expenses expected
Said on the Q1 FY27 call.
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹1,928.26 Cr+14.8% YoY-3% QoQ | ₹254.30 Cr+89.5% YoY+31.7% QoQ | ₹3.28+84.3% YoY+40.2% QoQ |
| Q2 FY25 | ₹1,988.39 Cr+12.3% YoY+7% QoQ | ₹193.08 Cr+5% YoY+11% QoQ | ₹2.34+1.7% YoY+6.4% QoQ |
| Q1 FY25 | ₹1,858.90 Cr+12.2% YoY+4.1% QoQ | ₹173.98 Cr+40.4% YoY-14.4% QoQ | ₹2.20+48.6% YoY-7.2% QoQ |
| Q4 FY24 | ₹1,785.88 Cr+8.7% YoY+6.3% QoQ | ₹203.14 Cr+46.9% YoY+51.3% QoQ | ₹2.37+34.7% YoY+33.1% QoQ |
| Q3 FY24 | ₹1,679.68 Cr+7.7% YoY-5.1% QoQ | ₹134.23 Cr-5.6% YoY-27% QoQ | ₹1.78+3.5% YoY-22.6% QoQ |
- Q1 FY27Positive tone
Delhi High Court ordered a court-supervised forensic audit into erstwhile promoter share dissipation, IHH's acquisition of control and use of funds for RHT assets, which Fortis and IHH say leaves operations, capex, bed expansion and M&A unrestricted and is expected to have no material adverse outcome.